Skip Navigation
Skip Website Tools
Website Tools
 ​ NIH_NIAID_Vertical_Logo_2Color.png
Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA) –
A Scientific Workshop to Promote Research Collaboration​​​​​​​​​​​​​​​
THIS WORKSHOP IS FULL AND CLOSED TO FURTHER ATTENDANCE!
Location:  Doha, Qatar
#MENAworkshop 
 
Local Co-H​​ost:  Weill Cornell Medical College-Qatar (WCMC-Q) with the Qatar National Research Fund (QNRF) of the Qatar Foundation
 
​Date:  26th – 29th May 2014 
 
Please note: This workshop will be held entirely in ENGLISH.
 
· Viral diseases of priority to the Middle East and North Africa (MENA) to include:
     o  Hepatitis C
    o Hepatitis E
    o HIV/AIDS
    o Coronaviruses, including the Middle East Respiratory Syndrome (MERS-CoV)
    o Flaviviruses, including Al-Khumra Virus  (ALKV)
    o Other viral diseases may be included in the agenda
 
· Types of Research: 
     o Basic, clinical and translational
    o Public health and epidemiology
    o Bioinformatics
    o Social and behavioral science
 
Objectives: 
· To present current scientific findings and research underway
· To discuss research challenges and opportunities in the region
· To share best practices information related to viral research bio-safety and bio-security
· To facilitate current and future research collaborations between investigators and institutions in MENA and the United States. To help achieve this objective, a competitive seed-grant program will be launched, through which eligible scientists may apply for collaborative research awards.
 
 
Participants: 
 
The majority of participants will include researchers and scientific program managers at all levels from  academic centers, governmental agencies, international organizations, non-governmental organizations, and other private and public institutions  from the United States and MENA countries including: Afghanistan, Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, Turkey, United Arab Emirates, and Yemen.
 

Scientists interested in participating in this consultation must submit an abstract for an oral or poster presentation through this website​.  Abstracts received prior to the submission deadline will be peer-reviewed. Based on the merit of submitted abstracts, some individuals will be invited to participate as either speakers or poster presenters. Limited travel support will be available to selected speakers and poster presenters.  
 
Sponsors: 
 
·         This scientific consultation is sponsored by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases (HHS/NIH/NIAID) and Office of Rare Diseases (NIH/ORD), the U.S. Department of State Bio-engagement Program (BEP), the Weill Cornell Medical College-Qatar (WCMC-Q) with the Qatar National Research Fund (QNRF) of the Qatar Foundation and the Hamad Medical Corporation, Sidra Medical and Research Center, and Qatar's Supreme Council of Health.
·         The seed grant program will be administered by CRDF-Global.
 
Scientific Agenda:   
The scientific program will be developed by an international Scientific Planning Committee established by the NIH/NIAID in consultation with the WCMC-Q and QNRF.
 FOR MORE INFORMATION ON ABSTRACT SUBMISSION, CLICK HERE​​​​​​.  
The deadline for abstract submission will be Thursday, April 24, 2014.    
If you have any questions, please email:
M. Jane Coury 
or
Elizabeth Dillard 
 
 
 The views expressed in written workshop materials or publications and by speakers and moderators at HHS-sponsored workshops do not necessarily reflect the official policies of the Department of Health and Human Services (HHS), nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Last Updated February 04, 2014

Last Reviewed February 04, 2014